Live Breaking News & Updates on Ignace Vergote

Stay updated with breaking news from Ignace vergote. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer

Tisotumab vedotin reduced risk of death by 30% compared with chemotherapy ....

Region Flamande , United States , Krishnansu Tewari , Mike Bassett , Catholic University Of Leuven , European Society For Medical Oncology , Leuven Cancer Institute , University Of California Irvine , Ignace Vergote , Catholic University , European Society , Medical Oncology ,

Gathering Insights in Gastrointestinal Cancers From ESMO 2023: Dr Pietrantonio

OncLive® will be LIVE with OncLive® News Network: On Location at the 2023 ESMO Congress. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference. ....

Jacob Sands , Filippo Pietrantonio , Paolo Tarantino , Caroline Seymour , Yelena Janjigian , Onclive News Network , Welcome To Onclive News Network , Congress At Onclive , Onclive News , Im Caroline , Drs Jacob Sands , Ignace Vergote ,

Novocure Shares Plunge After Its Ovarian Cancer Treatment Fails to Meet Goal

Novocure shares plunged after the provider of cancer-fighting treatments reported a Phase 3 trial of its Tumor Treating Fields (TTFields) therapy for ovarian cancer patients failed to meet its goal. ....

Novocure Ttfields , William Doyle , Tumor Treating Fields , Chair William Doyle , Ignace Vergote ,

Karyopharm Announces Presentation of Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer

/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the. ....

Region Flamande , South Korea , United Kingdom , Hong Kong , United States , Kyongsang Bukto , Reshma Rangwala , Brian Slomovitz , Luxembourg Gynaecological Oncology Group , Foundation Inc , American Cancer Society , American Society Of Clinical Oncology , Gynecologic Oncology Group , Mount Sinai Medical Center , World Health Organization , Selective Inhibitor Of Nuclear Export , Karyopharm Therapeutics Inc , Information Department , Drug Administration , International Agency For Research On Cancer , Partners Inc , Leuven Cancer Institute , National Cancer Institute , European Network Of Gynaecological Oncological Trial Groups , University Of Leuven , Karyopharm Selective Inhibitor Of Nuclear Export ,

EC approves Libtayo® for metastatic cervical cancer

The EC has approved Libtayo® for metastatic cervical cancer and disease progression while on or after platinum-based chemotherapy. ....

Region Flamande , Regeneron Pharmaceuticals Inc , University Hospitals Leuven , Trial Steering Committee , European Union , European Medicines Agency , Clinical Sciences Of Oncology At Regeneron , European Commission , Regeneron Pharmaceuticals , Senior Vice President , Clinical Sciences , New England Journal , Ignace Vergote ,